Leidi.com Lei Jianping April 13
Jiangsu Zhiyuan Pharmaceutical Co., Ltd. (abbreviation: "Zhiyuan Pharmaceutical") recently submitted a prospectus for listing on the main board of the Shenzhen Stock Exchange.
Zhiyuan Pharmaceutical plans to raise 700 million yuan, of which 250 million yuan will be used for the reconstruction and expansion project of Zhiyuan Pharmaceutical's preparation production base, 290 million yuan will be used for the R&D center project, and 160 million yuan will be used to supplement working capital.
Annual revenue 860 million
Zhiyuan Pharmaceutical focuses on common skin problems, namely fungal infectious skin diseases, acne and rosacea, immune inflammatory skin diseases, scalp and hair problems, etc., to meet the diverse needs of patients, and develops therapeutic drugs to functional skin care products, "From head to toe" serialized products.
At present, the company produces a wide range of products, covering creams, ointments, gels, solutions and other skin external dosage forms.
According to the prospectus, the revenue of Zhiyuan Pharmaceutical in 2020, 2021, and 2022 will be 388 million yuan, 511 million yuan, and 860 million yuan respectively; the net profit will be 52.46 million yuan, 87.458 million yuan, and 134 million yuan; The net profits were 47.2837 million yuan, 72.2947 million yuan, and 126 million yuan respectively.
Wuxi Zhonghe controls 55.8% of the shares
Before the IPO, Wuxi Zhonghe directly held 35,132,378 shares of the company, accounting for 27.05% of the company's total share capital. , Wuxi Zhonghe indirectly controls 12.5% of the company's shares through Wuxi Langming, indirectly controls 9.6% of the company's shares through Wuxi Longwei, and indirectly controls 6.66% of the company's shares through Wuxi Langyi.
Wuxi Zhonghe directly and indirectly controls 55.81% of the company's shares and is the controlling shareholder of the company.
In addition, Gangyong Company holds 7.47%, Wuxi Longxing holds 6.69%, Wuxi Jinrunyang holds 6.5%, Zhenbaolu Company holds 4.34%, Wuxi Zhiwen holds 3.43%, Gangning Company holds The shares are 2.69%, Pingtan Wenzhou holds 2.31%, and Jiangsu Zhongde holds 2.27%;
Wuxi Boyi holds 1.84%, Shenzhen Jinyi holds 1.43%, Hubei Tongying holds 1.14%, Wuxi Jinling holds 0.98%, Wuxi Yunlin holds 0.77%, and Yangzhou Jiatai holds 0.67%, Wuxi Zhiyue holds 0.64%, Jincheng Hefeng holds 0.61%, and Jincheng Xingao holds 0.41%.
After the IPO, Wuxi Zhonghe holds 20.28% of the shares, Wuxi Longming holds 9.38%, Wuxi Longwei holds 7.2%, Gangyong Company holds 5.6%, Wuxi Longxing holds 5.01%, Wuxi Lang Wuxi Jinrunyang holds 5% of the shares, Wuxi Jinrunyang holds 4.88%, and Zhenbao Road Company holds 3.25%.
Wuxi Zhiwen holds 2.57%, Gangning Company holds 2.02%, Pingtan Wenzhou holds 1.73%, and Jiangsu Zhongde holds 1.7%;
Wuxi Boyi holds 1.38%, Shenzhen Jinyi holds 1.07%, Hubei Tongying holds 0.85%, Wuxi Jinling holds 0.74%, Wuxi Yunlin holds 0.58%, and Yangzhou Jiatai holds 0.5%, Wuxi Zhiyue holds 0.48%, Jincheng Hefeng holds 0.45%, and Jincheng Xingao holds 0.31%.
———————————————
Lei Di was founded by Lei Jianping, a media person. If you reprint, please indicate the source.
